Mark Agulnik

10.6k citations
143 papers · 6.9k · 4 hit papers · h-index 41

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 1%
    • Vascular Tumors and Angiosarcomas
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

Mark Agulnik

136 papers receiving 6.8k citations

Mark Agulnik's Hit Papers

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial 2024 · 187 citations
1870+4+8Years since publication100200300400

Peers

Mark Agulnik
Comparison fields: 5 of 127
  • Otorhinolaryngology 983
  • Oncology 2.8k
  • Pulmonary and Respiratory Medicine 2.7k
  • Cancer Research 515
  • Gastroenterology 183
Replace Antonio Lopez Pousa with:
Antonio Lopez Pousa Spain
Salvatore Lo Vullo Italy
Didier Cupissol France
Heather Yan Lin United States
Federica Perrone Italy
Yong Chan Ahn South Korea
Ashley E. Winkler United States
Frédéric Peyrade France
Scott H. Okuno United States
Hakan Harputluoğlu Türkiye
Mark Agulnik relative to Antonio Lopez Pousa Spain Antonio Lopez Pousa's profile →
Citations per field
00.5×1.6×
Antonio Lopez Pousa · 1×
Citations per year

Countries citing papers authored by Mark Agulnik

Since Specialization
Citations

This map shows the geographic impact of Mark Agulnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Agulnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Agulnik more than expected).

Fields of papers citing papers by Mark Agulnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Agulnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Agulnik. The network helps show where Mark Agulnik may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Agulnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Agulnik Line = papers co-authored together Mark Agulnik links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
Hit paper breakdown →
2016488
2
Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Hit paper breakdown →
2014420
3 2018361
4 2012319
5 2020314
6 2017241
7 2017239
8
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Hit paper breakdown →
2022236
9 2007221
10 2007209
11 2019204
12
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Hit paper breakdown →
2024187
13 2013160
14 2016158
15 2022142
16 2009138
17 2008134
18 2021129
19 2018111
20 2016106

About Mark Agulnik

Mark Agulnik is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology, Pathology and Forensic Medicine and Gastroenterology, having authored 143 papers that have together received 6.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (45 papers), Head and Neck Cancer Studies (21 papers), CAR-T cell therapy research (14 papers), Vascular Tumors and Angiosarcomas (13 papers), Salivary Gland Tumors Diagnosis and Treatment (11 papers), Gastrointestinal Tumor Research and Treatment (11 papers), Cardiac tumors and thrombi (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Otorhinolaryngology (983 citations), Oncology (2.8k citations), Pulmonary and Respiratory Medicine (2.7k citations), Cancer Research (515 citations) and Gastroenterology (183 citations). Mark Agulnik has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lillian L. Siu, Joel Brian Epstein, Scott H. Okuno, Gregory R. Pond, Ari Joseph Rosenberg, Jessica Lee Yarber, Mario E. Lacouture, Bruce Brockstein, Brian Andrew Van Tine and Margaret von Mehren. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of the National Comprehensive Cancer Network, European Journal of Cancer and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact